Insider Trading activities of Nivalis Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nivalis Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nivalis Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Nivalis Therapeutics, Inc. since 2005. The reporting company's ticker symbol is NVLS. The reporting company's CIK number is 1626199.
The total value of stock buying since 2005 is $8,261,649.
The total value of stock sales since 2005 is $89,233.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Nivalis Therapeutics, Inc. (NVLS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-06 90,456 $206,134 0 $0 0 $0
2017-05 294,892 $679,218 0 $0 0 $0
2017-01 0 $0 6,687 $15,179 18,055 $0
2016-10 0 $0 5,820 $46,327 18,056 $0
2016-07 0 $0 5,950 $27,727 18,055 $0
2016-06 5,000 $19,345 0 $0 0 $0
2016-03 5,000 $21,085 0 $0 0 $0
2015-12 15,000 $121,500 0 $0 0 $0
2015-06 513,749 $7,214,367 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Nivalis Therapeutics, Inc. insiders (NVLS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-06-20 Lampert Mark N Buy 17,806 2.25 40,063
2017-06-07 Lampert Mark N Buy 36,900 2.28 84,168
2017-06-05 Lampert Mark N Buy 35,750 2.29 81,903
2017-05-31 Lampert Mark N Buy 28,100 2.25 63,140
2017-05-30 Lampert Mark N Buy 18,900 2.30 43,394
2017-05-19 Lampert Mark N Buy 11,600 2.30 26,679
2017-05-18 Lampert Mark N Buy 29,886 2.30 68,737
2017-05-17 Lampert Mark N Buy 37,372 2.30 85,918
2017-05-11 Lampert Mark N Buy 7,034 2.34 16,480
2017-05-10 Lampert Mark N Buy 62,000 2.35 145,452
2017-05-09 Lampert Mark N Buy 40,000 2.29 91,519
2017-05-09 Conway Robert E (Director) Buy 5,000 2.34 11,700
2017-05-08 Conway Robert E (Director) Buy 15,000 2.28 34,200
2017-05-05 Conway Robert E (Director) Buy 20,000 2.30 46,000
2017-05-05 Troha Janice (Exec Vice President / COO) Buy 10,000 2.34 23,400
2017-05-04 Conway Robert E (Director) Buy 10,000 2.26 22,599
2017-01-04 Rodman David Malcom (Exec Vice President and CMO) Sale 6,687 2.27 15,179
2017-01-03 Rodman David Malcom (Exec Vice President and CMO) Option Ex 18,055 .00 0
2016-10-04 Rodman David Malcom (Exec Vice President and CMO) Sale 5,820 7.96 46,327
2016-10-03 Rodman David Malcom (Exec Vice President and CMO) Option Ex 18,056 .00 0
2016-07-05 Rodman David Malcom (Exec Vice President and CMO) Sale 5,950 4.66 27,727
2016-07-01 Rodman David Malcom (Exec Vice President and CMO) Option Ex 18,055 .00 0
2016-06-16 Congleton Jon (President and CEO) Buy 5,000 3.87 19,345
2016-03-24 Congleton Jon (President and CEO) Buy 5,000 4.22 21,085
2015-12-11 Congleton Jon (President and CEO) Buy 5,000 8.10 40,500
2015-12-09 Conway Robert E (Director) Buy 10,000 8.10 81,000
2015-06-23 Deerfield Private Design International Ii, L.p. Buy 250,000 14.00 3,500,000
2015-06-22 Hawkes Bay Master Investors (cayman) L.p. (10% Owner) Buy 5,500 14.75 81,114
2015-06-22 Rock Springs Capital Management Lp (10% Owner) Buy 200,000 14.00 2,800,000
2015-06-19 Hawkes Bay Master Investors (cayman) L.p. (10% Owner) Buy 11,700 14.67 171,592
2015-06-18 Hawkes Bay Master Investors (cayman) L.p. (10% Owner) Buy 6,200 14.75 91,450
2015-06-17 Jennison Global Healthcare Master Fund, Ltd. (10% Owner) Buy 26,149 14.00 366,086
2015-06-17 Hawkes Bay Master Investors (cayman) L.p. (10% Owner) Buy 14,200 14.38 204,125

Insider trading activities including stock purchases, stock sales, and option exercises of NVLS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nivalis Therapeutics, Inc. (symbol NVLS, CIK number 1626199) see the Securities and Exchange Commission (SEC) website.